FDA Allows Marketing of Vuse Tobacco-Flavored Vapes
FRIDAY, July 19, 2024 (HealthDay News) — The U.S. Food and Drug Administration on Thursday authorized the sale of the country’s best-selling e-cigarette. The agency’s decision only applies to several tobacco-flavored versions of the reusable product, sold as Vuse. In January 2023, the FDA rejected R.J. Reynold’s application for itsContinue Reading